Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05271136Not ApplicableCompleted

A Clinical Study to Evaluate the Efficacy of an Anti-Aging Serum

Role: collaborator

NCT04065035Not ApplicableCompleted

A Clinical Study to Evaluate Efficacy and Tolerability of a Cosmetic Product for Arm Firming

Role: collaborator

NCT03719742Not ApplicableCompleted

A Clinical Study to Evaluate the Safety and Efficacy of a Baby Cleanser and a Moisturizer

Role: collaborator

NCT02288858Not ApplicableCompleted

To Evaluate the Effects of Viviscal Oral Supplements When Used by Females With Self-perceived Thinning Hair

Role: collaborator

All 4 trials loaded